http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2611659-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6601d87e935e08cffaa2e3e6341b7eb5 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 |
| filingDate | 2015-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2649c655b282f589a773cdfa42387843 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_424a9db39436751c2f33d2d72c5d7158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_006537fda8c4d6f373541fd2d1ebb80a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_151a54889cc2a4b10b73f778a7398cdd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_577c1d08ca9ebb826932ee577f87d318 |
| publicationDate | 2017-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2611659-C1 |
| titleOfInvention | Pharmaceutical ketorolac-based composition in form of nasal spray and method for preparation thereof |
| abstract | FIELD: pharmaceutics. n SUBSTANCE: invention relates to pharmaceutical industry and represents a pharmaceutical composition in form of nasal spray, having analgesic and anti-inflammatory activity, characterized by the fact that it comprises tromethamine ketorolac as an active substance and additives: phenoxyethanol as a antimicrobial preserving agent and antiseptic, poloxamer 407 as a humidifier, disodium edetate as a chelating agent, sodium hydroxide and potassium dihydrogen phosphate as a buffer mixture and a pH regulator and water for injections, wherein ingredients of composition are taken in certain ratio, wt%. n EFFECT: invention ensures increased storage life after primary opening up to 20 days, in conditions of a refrigerating chamber, and at room temperature, wider range of nasal sprays, having analgesic and anti-inflammatory activity, as well as storage life of 2 years. n 2 cl, 7 tbl |
| priorityDate | 2015-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.